Imipenem/funobactam (formerly XNW4107) in vivo pharmacodynamics against serine carbapenemase-producing Gram-negative bacteria: a novel modelling approach for time-dependent killing
ConclusionsImipenem/funobactam showed potentin vivo efficacy against serine carbapenemase-producers. The novel PK/PD index (%fT > CT)/MIC appeared to best describein vivo activity.
Source: Journal of Antimicrobial Chemotherapy - Category: Microbiology Source Type: research
More News: Chemotherapy | Microbiology